Clinical Trial: First-in Human Phase I Study of ISM3091 in Patients With Advanced Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Solid Tumor
Study Type: INTERVENTIONAL
Official Title: A Phase I, Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ISM3091 in Patients With Advanced Solid Tumors
Brief Summary:
This is a first-in-human, multicenter, open-label Phase I study.The study will be comprised of a dose escalation part followed by a dose selection optimization part.
Read more